Federico Pio Fabrizio, Associate of Molecular Biology at The Kore University of Enna, shared on LinkedIn:
“An excellent team effort involving IRCCS Fondazione Casa Sollievo della Sofferenza, the University of Palermo, the University of Naples ‘Federico II’ and the University of Enna ‘Kore’, focusing on epigenetics in lung cancer.
In our work published in Frontiers in Oncology, we explore the potential of cell-free DNA methylation as a non-invasive biomarker for the early detection and minimal residual disease monitoring of lung cancer.
A rapidly evolving field where epigenetics, liquid biopsy, machine learning, and multi-omics may contribute to making patient management increasingly precise and personalized.
A result made possible by collaboration, teamwork, and the sharing of expertise!
You can find here the manuscript.”
Title: Epigenetic profiling of circulating cell-free DNA for early detection and minimal residual disease assessment in lung cancer: a focus on DNA methylation
Authors: Tancredi Didier Bazan Russo, Valerio Gristina, Marco Donatello Delcuratolo, Leonardo Tamburi, Francesco Delli Muti, Filomena Mangiacotti, Clarissa Mujacic, Daniele Fanale, Antonio Galvano, Stefania Gori, Lorena Incorvaia, Antonio Giordano, Francesco Pepe, Umberto Malapelle, Antonio Russo, Lucia Anna Muscarella, Federico Pio Fabrizio
You can also read: Lung Cancer Screening in Women: 5 Breakthrough Insights Highlight New Risk Groups
